⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1268975 | 0.72 | — | — | |
| Iodide SCHEMBL10728122 | 0.70 | — | — | |
| SCHEMBL31322905 | 0.70 | — | — | |
| SCHEMBL7845005 | 0.67 | — | — | |
| SCHEMBL10719597 | 0.65 | — | — | |
| SCHEMBL4879869 | 0.64 | — | — | |
| Cyclohexene SCHEMBL29198043 | 0.64 | — | — | |
| SCHEMBL1507153 | 0.60 | POLB (0.34) | — | |
| SCHEMBL30403808 | 0.60 | SIGMAR1 (0.41) | — | |
| SCHEMBL11103519 | 0.54 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-104447517-B | Synthetic process of high-purity fluorinated reagent for developing novel anti-cancer drugs | 上海泰坦科技股份有限公司 | 2017-01-11 | — | — | CN | disclosed |
| CN-104447517-B | Synthetic process of high-purity fluorinated reagent for developing novel anti-cancer drugs | 上海泰坦科技股份有限公司 | 2017-01-11 | — | — | CN | disclosed |
| CN-104447517-A | Synthetic process of high-purity fluorinated reagent for developing novel anti-cancer drugs | SHANGHAI TITAN TECHNOLOGY CO LTD | 2015-03-25 | — | — | CN | disclosed |
| EP-2501703-B1 | SPIROPIPERIDINE COMPOUNDS AS ORL-1 RECEPTOR ANTAGONISTS | LILLY CO ELI (US) | 2013-09-18 | — | — | EP | disclosed |
| US-8232289-B2 | Spiropiperidine compounds as ORL-1 receptor antagonists | ELI LILLY AND COMPANY (US) | 2012-07-31 | — | — | US | disclosed |
| CN-102612520-A | Spiropiperidine compounds as orl-1 receptor antagonists | LILLY CO ELI | 2012-07-25 | — | — | CN | disclosed |
| US-20110118251-A1 | SPIROPIPERIDINE COMPOUNDS AS ORL-1 RECEPTOR ANTAGONISTS | ELI LILLY AND COMPANY (US) | 2011-05-19 | — | — | US | disclosed |